March 16, 2020

Dear Customer,

At Myriad, we are actively monitoring the COVID-19/Coronavirus situation and have implemented a business continuity plan to ensure the safety and well-being of our employees, our customers and their patients. We will continue to update this plan as this situation continues to develop.

We recognize that you and your patients still need test results rapidly from us to manage your patients’ care. As your trusted advisors, we will continue to provide our testing services without interruption or delay for as long as possible and will communicate with you immediately if anything changes our ability to do so.

Where possible, we offer technology-based solutions such as online test ordering and reporting as well as telephonic consults for patients to help improve social distancing strategies.

If you have any special needs or have any questions, please reach out to your Myriad sales representative or customer service at 1-800-469-7423.  We will do our best to respond the same day.  In the meantime, we will keep you informed if there are any changes to our business due to the coronavirus situation.

As always, thank you for being a Myriad customer and for your continued trust as we manage through this time together.

Bryan Riggsbee,

Interim President and CEO,

and Chief Financial Officer

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.